Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Clinical Outcomes Study: Amniotic and Umbilical Cord Tissue Administration for Orthopedic, Neurologic, Urologic, Autoimmune, Renal, Cardiac and Pulmonary Conditions

NCT03899298 is registered in ClinicalTrials.gov with R3 Stem Cell as lead sponsor.

NCT NCT03899298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03899298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Clinical Outcomes Study: Amniotic and Umbilical Cord Tissue Administration for Orthopedic, Neurologic, Urologic, Autoimmune, Renal, Cardiac and Pulmonary Conditions
Lead sponsor
R3 Stem Cell
Phase
Phase 1
Overall status
Not yet recruiting
Start date
September 1, 2019
Completion date
March 20, 2029
Enrollment
5,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, arthritis, autoimmune diseases, cardiac event, cardiomyopathies, chf, copd, erectile dysfunction, kidney diseases, neurologic disorder, neuropathy;peripheral, orthopedic disorder, pulmonary disease, renal failure, renal insufficiency, stroke, urologic diseases